Stage II and III post processing of NEXRAD precipitation estimates in the modernized weather service

被引：0
|
作者：
Breidenbach, JP [1 ]
Seo, DJ [1 ]
Fulton, R [1 ]
机构：
[1] Natl Weather Serv, Off Hydrol, Hydrol Res Lab, Silver Spring, MD 20910 USA
来源：
14TH INTERNATIONAL CONFERENCE ON INTERACTIVE INFORMATION AND PROCESSING SYSTEM (IIPS) FOR METEOROLOGY, OCEANOGRAPHY, AND HYDROLOGY | 1998年
关键词：
D O I：
暂无
中图分类号：
TP [自动化技术、计算机技术];
学科分类号：
0812 ;
摘要：
引用
收藏
页码：263 / 266
页数：4
相关论文
共 50 条
  • [41] Exploiting circulating tumor DNA (ctDNA) to intensify the adjuvant (adj) or post-adj treatment of stage III and highrisk stage II resected colon cancer patients (pts): The ERASE-CRC project by GONO
    Conca, V.
    Vetere, G.
    Moretto, R.
    Lonardi, S.
    Antoniotti, C.
    Germani, M. M.
    Pietrantonio, F.
    Bittoni, A.
    Carullo, M.
    Salvatore, L.
    Boccaccino, A.
    Ronzoni, M.
    Ricagno, G.
    Toma, I.
    Cupini, S.
    Latiano, T. P.
    Arcangeli, G.
    Masi, G.
    Fassan, M.
    Cremolini, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S70 - S70
  • [42] Use of circulating tumor DNA (ctDNA) to affect the adjuvant or post-adjuvant treatment of patients with stage III and high-risk stage II resected colon cancer: The ERASE-CRC project by GONO
    Conca, Veronica
    Vetere, Guglielmo
    Moretto, Roberto
    Lonardi, Sara
    Antoniotti, Carlotta
    Germani, Marco Maria
    Pietrantonio, Filippo
    Bittoni, Alessandro
    Carullo, Martina
    Salvatore, Lisa
    Boccaccino, Alessandra
    Ronzoni, Monica
    Ricagno, Gianmarco
    Toma, Ilaria
    Cupini, Samanta
    Latiano, Tiziana Pia
    Arcangeli, Giuseppina
    Masi, Gianluca
    Fassan, Matteo
    Cremolini, Chiara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial (vol 12, 1, 2020)
    Barni, Sandro
    Rosati, Gerardo
    Lonardi, Sara
    Pella, Nicoletta
    Banzi, Maria
    Zampino, Maria G.
    Dotti, Katia F.
    Rimassa, Lorenza
    Marchetti, Paolo
    Maiello, Evaristo
    Artioli, Fabrizio
    Ferrari, Daris
    Labianca, Roberto
    Bidoli, Paolo
    Zaniboni, Alberto
    Sobrero, Alberto
    Iaffaioli, Vincenzo
    De Placido, Sabino
    Frassineti, Gian Luca
    Ciarlo, Andrea
    Buonadonna, Angela
    Silvestris, Nicola
    Piazza, Elena
    Pavesi, Lorenzo
    Moroni, Mauro
    Clerico, Mario
    Aglietta, Massimo
    Giordani, Paolo
    Galli, Francesca
    Galli, Fabio
    Petrelli, Fausto
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [44] Characteristics associated with nonreceipt of post-treatment surveillance testing in stage II and III colon cancer survivors and the subsequent relationship with overall survival and the cumulative incidence of cancer death
    Hines, Robert B.
    Jiban, Md Jibanul Haque
    Lee, Eunkyung
    Odahowski, Cassie
    Wallace, Audrey
    Adams, Spencer J. E.
    Rahman, Saleh
    Zhang, Shunpu
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer Reply
    Kumar, Sameera S.
    McGarry, Ronald C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (04): : 1080 - 1080
  • [46] TBCRC 002: A phase II, randomized, open label trial of preoperative letrozole versus letrozole (LET) in combination with bevacizumab (BEV) in post-menopausal women with newly diagnosed stage II/III breast cancer
    Forero-Torres, Andres
    Rugo, Hope S.
    Vaklavas, Christos
    Lin, Nancy U.
    Carey, Lisa A.
    Liu, Minetta C.
    Nanda, Rita
    Puhalla, Shannon
    Storniolo, Anna Maria
    Krontiras, Helen
    Saleh, Mansoor N.
    Li, Yufeng
    LoBuglio, Albert F.
    De Los Santos, Jennifer F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study
    Shinya Abe
    Kazushige Kawai
    Hiroaki Nozawa
    Kazuhito Sasaki
    Koji Murono
    Shigenobu Emoto
    Tsuyoshi Ozawa
    Yuichiro Yokoyama
    Yuzo Nagai
    Hiroyuki Anzai
    Hirofumi Sonoda
    Shinichi Yamauchi
    Kenichi Sugihara
    Soichiro Ishihara
    BMC Cancer, 22
  • [48] Detection of minimal residual disease (MRD) in colorectal cancer (CRC) patients UICC stage II/III by ultra-deep sequencing of cfDNA from post-surgery plasma
    McNamara, Sylvie
    Patel, Rajesh D.
    Adams, Hans-Peter
    Qu, Xueping
    Hinzmann, Bernd
    Wong, Cheryl V.
    Heilek, Gabrielle
    Mantke, Rene
    Heise, Michael
    Steinmueller, Thomas
    Pross, Matthias
    Marusch, Frank
    Bais, Carlos
    Palma, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [49] Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study
    Abe, Shinya
    Kawai, Kazushige
    Nozawa, Hiroaki
    Sasaki, Kazuhito
    Murono, Koji
    Emoto, Shigenobu
    Ozawa, Tsuyoshi
    Yokoyama, Yuichiro
    Nagai, Yuzo
    Anzai, Hiroyuki
    Sonoda, Hirofumi
    Yamauchi, Shinichi
    Sugihara, Kenichi
    Ishihara, Soichiro
    BMC CANCER, 2022, 22 (01)
  • [50] Concomitant depletion of PTEN and p27 and overexpression of cyclin D1 may predict a worse prognosis for patients with post-operative stage II and III colorectal cancer
    Li, Jing
    Yin, Lin-Lin
    Su, Ke-Li
    Zhang, Gang-Feng
    Wang, Jing
    ONCOLOGY LETTERS, 2014, 8 (04) : 1543 - 1550
12345